Ocular disease in immunosuppressed patients.
New therapies and diseases causing immunosuppression have provoked new and devastating ocular diseases. The possible reasons for the vulnerability of the retina to opportunistic infections are discussed. The clinical patterns of disease caused by common opportunistic agents are described, and current treatment available is reviewed.
Sarkies
N J
NJ
Blach
R K
RK
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000212:Acyclovir / Q000627:therapeutic use; D000328:Adult; D002177:Candidiasis / Q000150:complications; D002825:Chorioretinitis / Q000150:complications; D003586:Cytomegalovirus Infections / Q000150:complications; D005128:Eye Diseases / Q000188:drug therapy / Q000209:etiology*; D006561:Herpes Simplex / Q000150:complications; D006562:Herpes Zoster / Q000150:complications; D006801:Humans; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007231:Infant, Newborn; D012160:Retina / Q000276:immunology; D012164:Retinal Diseases / Q000150:complications; D012171:Retinal Vessels
D000212:Acyclovir